These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26567731)

  • 1. Integration of (18)FDG-PET Metabolic and Functional Connectomes in the Early Diagnosis and Prognosis of the Alzheimer's Disease.
    Zippo AG; Castiglioni I
    Curr Alzheimer Res; 2016; 13(5):487-97. PubMed ID: 26567731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
    Mosconi L
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):486-510. PubMed ID: 15747152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.
    Chen X; Zhou Y; Wang R; Cao H; Reid S; Gao R; Han D;
    PLoS One; 2016; 11(5):e0154406. PubMed ID: 27183116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity.
    Marchitelli R; Aiello M; Cachia A; Quarantelli M; Cavaliere C; Postiglione A; Tedeschi G; Montella P; Milan G; Salvatore M; Salvatore E; Baron JC; Pappatà S
    Neuroimage; 2018 Aug; 176():246-258. PubMed ID: 29709628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
    Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L;
    J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Neurosci Methods; 2015 Dec; 256():168-83. PubMed ID: 26318777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
    Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer's disease.
    Foster NL; Wang AY; Tasdizen T; Fletcher PT; Hoffman JM; Koeppe RA
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S29-36. PubMed ID: 18631997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of estimation of brain volume and 2-deoxy-2-(18)F-fluoro-D-glucose metabolism using a novel automated image analysis method: application in Alzheimer's disease.
    Musiek ES; Saboury B; Mishra S; Chen Y; Reddin JS; Newberg AB; Udupa JK; Detre JA; Hofheinz F; Torigian D; Alavi A
    Hell J Nucl Med; 2012; 15(3):190-6. PubMed ID: 23106049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural substrates of cognitive reserve in Alzheimer's disease spectrum and normal aging.
    Lee DH; Lee P; Seo SW; Roh JH; Oh M; Oh JS; Oh SJ; Kim JS; Jeong Y
    Neuroimage; 2019 Feb; 186():690-702. PubMed ID: 30503934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid PET-MRI in Alzheimer's Disease Research.
    Mainta IC; Vargas MI; Trombella S; Frisoni GB; Unschuld PG; Garibotto V
    Methods Mol Biol; 2018; 1750():185-200. PubMed ID: 29512073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.
    Smailagic N; Lafortune L; Kelly S; Hyde C; Brayne C
    J Alzheimers Dis; 2018; 64(4):1175-1194. PubMed ID: 30010119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.
    Parent MJ; Zimmer ER; Shin M; Kang MS; Fonov VS; Mathieu A; Aliaga A; Kostikov A; Do Carmo S; Dea D; Poirier J; Soucy JP; Gauthier S; Cuello AC; Rosa-Neto P
    J Neurosci; 2017 Dec; 37(50):12263-12271. PubMed ID: 29097597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical Voxel-Based Methods and [18F]FDG PET Brain Imaging: Frontiers for the Diagnosis of AD.
    Gallivanone F; Della Rosa PA; Castiglioni I
    Curr Alzheimer Res; 2016; 13(6):682-94. PubMed ID: 26567733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease.
    Kawachi T; Ishii K; Sakamoto S; Sasaki M; Mori T; Yamashita F; Matsuda H; Mori E
    Eur J Nucl Med Mol Imaging; 2006 Jul; 33(7):801-9. PubMed ID: 16550383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG-PET in early AD diagnosis.
    Chew J; Silverman DH
    Med Clin North Am; 2013 May; 97(3):485-94. PubMed ID: 23642583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging Biomarkers of Neurodegeneration in Alzheimer's Disease: Distinct Contributions of Cortical MRI Atrophy and FDG-PET Hypometabolism.
    Benvenutto A; Giusiano B; Koric L; Gueriot C; Didic M; Felician O; Guye M; Guedj E; Ceccaldi M
    J Alzheimers Dis; 2018; 65(4):1147-1157. PubMed ID: 30124446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiscale deep neural network based analysis of FDG-PET images for the early diagnosis of Alzheimer's disease.
    Lu D; Popuri K; Ding GW; Balachandar R; Beg MF;
    Med Image Anal; 2018 May; 46():26-34. PubMed ID: 29502031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and prognosis of prodromal Alzheimer's disease as assessed by magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography in a community: reanalysis from the Osaki-Tajiri Project.
    Meguro K; Akanuma K; Meguro M; Yamaguchi S; Ishii H; Tashiro M
    Psychogeriatrics; 2016 Mar; 16(2):116-20. PubMed ID: 26114837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.